30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Astria Therapeutics Inc (ATXS)

Track

Stock chart
Ticker: ATXS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Morabito Christopher
Chief Medical Officer
1 sale — total 135,939 USD
Planned sale 1 Apr 2024
Value US$4,112,102.91 | Price 16.66 | Shares 55,191
Proposed sale 1 Apr 2024
Value US$3,401,856.25 | Price 453.22 | Shares 52,016
Buy 1 Feb 2024
Value US$29,999,521.50 | Price 12.09 | Shares 2,481,350
Planned sale 29 Jan 2024
Value US$102,552.40 | Price 11.15 | Shares 9,200
Proposed sale 29 Jan 2024
Value US$102,552.40 | Price 11.15 | Shares 9,200
Planned sale 26 Jan 2024
Value US$8,812.00 | Price 11.02 | Shares 800
Buy 21 Dec 2023
Value US$4,588,000.00 | Price 6.20 | Shares 740,000
Buy 16 Oct 2023
Value US$2,999,996.64 | Price 6.51 | Shares 460,546
Buy 16 Oct 2023
Value US$3,999,999.87 | Price 6.51 | Shares 614,062
Buy 19 Dec 2022
Value US$9,999,997.65 | Price 11.01 | Shares 908,265
Buy 19 Nov 2021
Value US$669.50 | Price 6.70 | Shares 100
Buy 30 Jun 2015
Value US$149,064.00 | Price 12.00 | Shares 12,422
Buy 30 Jun 2015
Value US$1,093,992.00 | Price 12.00 | Shares 91,166
Buy 30 Jun 2015
Value US$1,862,256.00 | Price 12.00 | Shares 155,188
Buy 30 Jun 2015
Value US$4,520,340.00 | Price 12.00 | Shares 376,695
Buy 30 Jun 2015
Value US$2,681,268.00 | Price 12.00 | Shares 223,439
Buy 30 Jun 2015
Value US$97,128.00 | Price 12.00 | Shares 8,094
Buy 30 Jun 2015
Value US$4,595,952.00 | Price 12.00 | Shares 382,996
Buy 30 Jun 2015
Value US$4,520,340.00 | Price 12.00 | Shares 376,695
Buy 30 Jun 2015
Value US$2,681,268.00 | Price 12.00 | Shares 223,439
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-03 2024-04-01 PlS Planned sale
2.5
Morabito Christopher

Chief Medical Officer

Officer
55,191 -36.4%
16.66
US$4,112,103 		55,191 -36.4% 16.66 US$4,112,103
2024-04-01 2024-04-01 PrS Proposed sale
2.5
CHRIS MORABITO

Officer

Officer
52,016
453.22
US$3,401,856 		52,016 453.22 US$3,401,856
2024-02-05 2024-02-01 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director
87,070 -43.1%
435.14
US$1,289,623 		87,070 -43.1% 435.14 US$1,289,623
2024-01-30 2024-01-29 PlS Planned sale
2.5
Morabito Christopher

Chief Medical Officer

Officer
9,200 -100.0%
11.15
US$102,552 		9,200 -100.0% 11.15 US$102,552
2024-01-29 2024-01-29 PrS Proposed sale
2.5
CHRISTOPHER MORABITO

Officer

Officer
9,200
11.15
US$102,552 		9,200 11.15 US$102,552
2024-01-30 2024-01-26 PlS Planned sale
2.5
Morabito Christopher

Chief Medical Officer

Officer
800 -100.0%
11.02
US$8,812 		800 -100.0% 11.02 US$8,812
2023-12-22 2023-12-21 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director
740,000 +44.8%
6.20
US$4,588,000 		740,000 +44.8% 6.20 US$4,588,000
2023-10-18 2023-10-16 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director
460,546 +40.0%
6.51
US$2,999,997 		460,546 +40.0% 6.51 US$2,999,997
2023-10-18 2023-10-16 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director
614,062 +59.1%
6.51
US$4,000,000 		614,062 +59.1% 6.51 US$4,000,000
2022-12-21 2022-12-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director
908,265 +698.4%
11.01
US$9,999,998 		908,265 +698.4% 11.01 US$9,999,998
2021-11-23 2021-11-19 B Purchase
0.9
Komjathy Andrew

Chief Commercial Officer

Officer
100 +inf%
6.70
US$670 		100 +inf% 6.70 US$670
2015-06-30 2015-06-30 B Purchase George Jean Non-Executive Director
12,422 +15.9%
12.00
US$149,064 		12,422 +15.9% 12.00 US$149,064
2015-06-30 2015-06-30 B Purchase George Jean Non-Executive Director
91,166 +15.9%
12.00
US$1,093,992 		91,166 +15.9% 12.00 US$1,093,992
2015-06-30 2015-06-30 B Purchase George Jean Non-Executive Director
155,188 +15.9%
12.00
US$1,862,256 		155,188 +15.9% 12.00 US$1,862,256
2015-06-30 2015-06-30 B Purchase GALAKATOS NICHOLAS Non-Executive Director Large shareholder
376,695 +15.9%
12.00
US$4,520,340 		376,695 +15.9% 12.00 US$4,520,340
2015-06-30 2015-06-30 B Purchase Laufer Ron Non-Executive Director Large shareholder
223,439 +15.9%
12.00
US$2,681,268 		223,439 +15.9% 12.00 US$2,681,268
2015-06-30 2015-06-30 B Purchase SVLSF V, LLC Large shareholder
8,094 +15.9%
12.00
US$97,128 		8,094 +15.9% 12.00 US$97,128
2015-06-30 2015-06-30 B Purchase SVLSF V, LLC Large shareholder
382,996 +15.9%
12.00
US$4,595,952 		382,996 +15.9% 12.00 US$4,595,952
2015-06-30 2015-06-30 B Purchase Clarus Lifesciences II, L.P. Large shareholder
376,695 +15.9%
12.00
US$4,520,340 		376,695 +15.9% 12.00 US$4,520,340
2015-06-30 2015-06-30 B Purchase MedImmune Ventures, Inc. Large shareholder
223,439 +15.9%
12.00
US$2,681,268 		223,439 +15.9% 12.00 US$2,681,268
Explore more

More insider trading research around Astria Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America